Holiday Coverage - The CCTG Central Office will be closed on Canada Day, Wednesday, July 1st and will be open with coverage of critical activities on Thursday July 2nd and Friday July 3rd due to Queen's University wide holidays. All regular web-based applications (i.e. MANGO, GCP) will continue to be available. Regular business hours will resume on Monday, July 6 at 8:30 am EST. Have a safe and Happy Canada Day!

Wednesday, July 1 - CLOSED | Thursday, July 2 - OPEN - 9:00am – 5:00pm (limited coverage team) | Friday, July 3 - OPEN - 9:00am – 5:00pm (limited coverage team)

  For the latest COVID-19 (Coronavirus) information: CCTG public updates | CCTG member information

Dr. Sarit Assouline MD, MsC, FRCPC

Dr. Sarit Assouline MD, MsC, FRCPC
CCTG Hematologic Disease Site Chair

Dr. Sarit Assouline is a hematologist at the Jewish General Hospital, and an associate professor in the Department of Medicine at McGill University. She specializes in the treatment of hematological malignancies, leukemia and lymphoma in particular. Her research interests lie in the clinical development of new therapies for the treatment of these cancers. She has conducted or participated in over 100 clinical trials in leukemia and lymphoma, and has published widely on the subject. She is currently the associate director of the Clinical Research Unit, Segal Cancer Center of the Jewish General Hospital. In addition, she has recently been appointed the co-chair of the hematology disease site group for the Canadian Cancer Trials Group (CCTG), and the leukemia co-chair. In this new role, she is involved in the development of academic clinical trials for leukemia and lymphoma for patients across Canada. Dr. Assouline is also a Chercheur Clinicien, funded by the FRSQ (Fonds de recherche en santé du Québec) since 2010

Research Interests:

  • Research programs that focus on the design and conduct of numerous clinical trials testing novel therapies in patients with leukemia and lymphoma
  • Novel targeted monoclonal antibody therapies, proteasome inhibitors, histone deacetylase inhibitors, and drugs targeting protein translation.

Publications

  • Current publications list at PubMed

CCTG Hematologic Disease Site Committee page